{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:27:04Z","timestamp":1768296424898,"version":"3.49.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Describe \u03b22-agonists, steroids, hypertonic saline (HTS), n-acetylcysteine (NAC), and dornase alfa (DA) use to treat bronchiolitis, factors associated with use, and associations between use and PICU length of stay (LOS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective, multicenter cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>PICUs in the Pediatric Health Information System database.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>PICU admitted children 24 months young or younger with bronchiolitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We analyzed 47,520 hospitalizations between July 1, 2018, and June 30, 2022. We calculated the rate of medication use overall and the median (range) rate for each hospital: \u03b22-agonist (24,984\/47,520 [52.6%]; median hospital, 51.7% [21.4\u201381.7%]), steroid (15,878\/47,520 [33.4%]; median hospital, 33.4% [6.0\u201354.8%]), HTS (7,041\/47,520 [14.8%]; median hospital, 10.5% [0\u201366.1%]), NAC (1,571\/47,520 [3.3%]; median hospital, 0.8% [0\u201322.0%], and DA (840\/47,520 [1.8%]; median hospital, 1.4% [0\u201313.6%]). Logistic regression using generalized estimating equations (GEEs) identified associations between concurrent asthma and \u03b22-agonist (adjusted odds ratio [aOR], 8.68; 95% CI, 7.08\u201310.65; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001) and steroid (aOR, 10.10; 95% CI, 8.84\u201311.53; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001) use. Mechanical ventilation was associated with all medications: \u03b22-agonists (aOR, 1.79; 95% CI, 1.57\u20132.04; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), steroids (aOR, 2.33; 95% CI, 1.69\u20133.21; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), HTS (aOR, 1.82; 95% CI, 1.47\u20132.25; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), NAC (aOR, 3.29; 95% CI, 2.15\u20135.03; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), and DA (aOR, 7.65; 95% CI, 4.30\u201313.61; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). No medication was associated with decreased PICU LOS. To assess changes in medication use over time and associations with the 2014 American Academy of Pediatrics bronchiolitis guidelines, we expanded our analysis to 83,820 hospitalizations between July 1, 2009, and June 30, 2022. Logistic regression with GEEs found no change in \u03b22-agonist use; steroid use increased after guideline publication (aOR, 1.05; 95% CI, 1.01\u20131.10; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02), HTS use changed from increasing prior to the guidelines (aOR, 1.32; 95% CI, 1.11\u20131.56; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001) to stable since guideline publication (aOR, 0.93; 95% CI, 0.81\u20131.07; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.33).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>\u03b22-agonists, steroids, and HTS are commonly, but variably used for PICU bronchiolitis treatment. Medication use appears relatively stable over the last decade.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003670","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T15:16:17Z","timestamp":1734448577000},"page":"e294-e303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Use of \u03b2-2 Agonists, Steroids, and Mucoactive Medications to Treat Bronchiolitis in the PICU: U.S. Pediatric Health Information System 2009\u20132022 Database Study"],"prefix":"10.1097","volume":"26","author":[{"given":"Brian F.","family":"Flaherty","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody S.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Coon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington School of Medicine, Seattle, WA."},{"name":"Department of Pediatrics, Division of Hospital Medicine, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendu","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hospital Medicine, University of Utah, Salt Lake City, UT."},{"name":"Healthcare Delivery Institute, Intermountain Health, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence J.","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather T.","family":"Keenan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Critical Care, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"R1-20250306","doi-asserted-by":"crossref","first-page":"1601648","DOI":"10.1183\/13993003.01648-2016","article-title":"Burden of disease and change in practice in critically ill infants with bronchiolitis.","volume":"49","author":"Schlapbach","year":"2017","journal-title":"Eur Respir J"},{"key":"R2-20250306","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcrc.2021.07.009","article-title":"Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study.","volume":"68","author":"Linssen","year":"2022","journal-title":"J Crit Care"},{"key":"R3-20250306","doi-asserted-by":"crossref","first-page":"e2117816","DOI":"10.1001\/jamanetworkopen.2021.17816","article-title":"Identifying conditions with high prevalence, cost, and variation in cost in US children\u2019s hospitals.","volume":"4","author":"Gill","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20250306","doi-asserted-by":"crossref","first-page":"e20192614","DOI":"10.1542\/peds.2019-2614","article-title":"Trends in bronchiolitis hospitalizations in the United States: 2000-2016.","volume":"144","author":"Fujiogi","year":"2019","journal-title":"Pediatrics"},{"key":"R5-20250306","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PCC.0000000000002878","article-title":"Hospital charges associated with critical bronchiolitis from 2009 to 2019.","volume":"23","author":"Slain","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R6-20250306","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00134-022-06918-4","article-title":"Clinical practice guidelines: Management of severe bronchiolitis in infants under 12 months old admitted to a pediatric critical care unit.","volume":"49","author":"Milesi","year":"2023","journal-title":"Intensive Care Med"},{"key":"R7-20250306","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1542\/hpeds.2023-007120","article-title":"Intensivists\u2019 reported management of critical bronchiolitis: More data and new guidelines needed.","volume":"13","author":"Zurca","year":"2023","journal-title":"Hosp Pediatr"},{"key":"R8-20250306","doi-asserted-by":"crossref","first-page":"2565397","DOI":"10.1155\/2017\/2565397","article-title":"Prospective multicentre study on the epidemiology and current therapeutic management of severe bronchiolitis in Spain.","volume":"2017","author":"Flores-Gonzalez","year":"2017","journal-title":"Biomed Res Int"},{"key":"R9-20250306","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/hpeds.2014-0125","article-title":"Variability of intensive care management for children with bronchiolitis.","volume":"5","author":"Pierce","year":"2015","journal-title":"Hosp Pediatr"},{"key":"R10-20250306","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ppul.23974","article-title":"Treatment of severe bronchiolitis: A survey of Canadian pediatric intensivists.","volume":"53","author":"Bradshaw","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"R11-20250306","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00431-018-3156-4","article-title":"The change in management of bronchiolitis in the intensive care unit between 2000 and 2015.","volume":"177","author":"Mecklin","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R12-20250306","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/jpc.14371","article-title":"Nebulised hypertonic saline in children with bronchiolitis admitted to the paediatric intensive care unit: A retrospective study.","volume":"55","author":"Stobbelaar","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"R13-20250306","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.medin.2019.10.006","article-title":"Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit.","volume":"45","author":"Guitart","year":"2019","journal-title":"Med Intensiva"},{"key":"R14-20250306","first-page":"8","article-title":"Rational use of mucoactive medications to treat pediatric airway disease.","volume":"36","author":"Linssen","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"R15-20250306","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: The diagnosis, management, and prevention of bronchiolitis.","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"key":"R16-20250306","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpeds.2016.06.035","article-title":"Pediatric critical care resource use by children with medical complexity.","volume":"177","author":"Chan","year":"2016","journal-title":"J Pediatr"},{"key":"R17-20250306","doi-asserted-by":"crossref","first-page":"e2129920","DOI":"10.1001\/jamanetworkopen.2021.29920","article-title":"Trends in hospital costs and levels of services provided for children with bronchiolitis treated in children\u2019s hospitals.","volume":"4","author":"Willer","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R18-20250306","doi-asserted-by":"crossref","first-page":"e20162642","DOI":"10.1542\/peds.2016-2642","article-title":"Characterization of inpatient cystic fibrosis pulmonary exacerbations.","volume":"139","author":"Cogen","year":"2017","journal-title":"Pediatrics"},{"key":"R19-20250306","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: Updated for ICD-10 and complex medical technology dependence and transplantation.","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"R20-20250306","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/infdis\/jiaa435","article-title":"Respiratory syncytial virus and all-cause bronchiolitis hospitalizations among preterm infants using the Pediatric Health Information System (PHIS).","volume":"225","author":"Fergie","year":"2022","journal-title":"J Infect Dis"},{"key":"R21-20250306","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamapediatrics.2013.186","article-title":"Identifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codes.","volume":"167","author":"Williams","year":"2013","journal-title":"JAMA Pediatr"},{"key":"R22-20250306","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1542\/hpeds.2020-001800","article-title":"Variation in management and outcomes of children with complicated pneumonia.","volume":"11","author":"Gross","year":"2021","journal-title":"Hosp Pediatr"},{"key":"R23-20250306","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpeds.2005.05.008","article-title":"Regional variation in ICU care for pediatric patients with asthma.","volume":"147","author":"Bratton","year":"2005","journal-title":"J Pediatr"},{"key":"R24-20250306","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ppul.24054","article-title":"Identification of hospitalized tracheostomy and ventilator dependent patients in administrative data.","volume":"53","author":"Giambra","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"R25-20250306","first-page":"46","article-title":"A closer look at all-patient refined DRGs.","volume":"73","author":"Averill","year":"2002","journal-title":"J AHIMA"},{"key":"R26-20250306","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12913-023-09333-7","article-title":"Severity of illness and risk of mortality in Mayo Clinic\u2019s virtual hybrid advanced care at home program: A retrospective cohort study.","volume":"23","author":"Paulson","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"R27-20250306","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0039-3400467","article-title":"The effects of furosemide on oxygenation in mechanically ventilated children with bronchiolitis.","volume":"9","author":"Kulkarni","year":"2020","journal-title":"J Pediatr Intensive Care"},{"key":"R28-20250306","doi-asserted-by":"crossref","first-page":"e2339884","DOI":"10.1001\/jamanetworkopen.2023.39884","article-title":"Admissions for bronchiolitis at children\u2019s hospitals before and during the COVID-19 pandemic.","volume":"6","author":"Remien","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R29-20250306","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/archdischild-2018-315199","article-title":"Management of severe bronchiolitis: Impact of NICE guidelines.","volume":"105","author":"Griffiths","year":"2020","journal-title":"Arch Dis Child"},{"key":"R30-20250306","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00431-023-04940-2","article-title":"Twenty-one-year follow-up revealed guideline-concordant and non-concordant trends in intensive care of bronchiolitis.","volume":"182","author":"Selin","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R31-20250306","doi-asserted-by":"crossref","first-page":"101257","DOI":"10.1016\/j.eclinm.2021.101257","article-title":"Identifying and predicting severe bronchiolitis profiles at high risk for developing asthma: Analysis of three prospective cohorts.","volume":"43","author":"Fujiogi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R32-20250306","first-page":"53","article-title":"The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?","volume":"34","author":"Rodriguez-Martinez","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"R33-20250306","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/CCM.0b013e318218a030","article-title":"Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: A randomized controlled trial.","volume":"39","author":"van Woensel","year":"2011","journal-title":"Crit Care Med"},{"key":"R34-20250306","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpeds.2022.01.031","article-title":"Pragmatic randomized trial of corticosteroids and inhaled epinephrine for bronchiolitis in children in intensive care.","volume":"244","author":"Gelbart","year":"2022","journal-title":"J Pediatr"},{"key":"R35-20250306","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/ppul.26481","article-title":"Dornase alfa in mechanically ventilated children with bronchiolitis: A retrospective cohort study.","volume":"58","author":"Vettleson","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"R36-20250306","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/apa.13162","article-title":"Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children.","volume":"105","author":"Tapiainen","year":"2016","journal-title":"Acta Paediatr"},{"key":"R38-20250306","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ijcp.12043","article-title":"Therapeutic momentum: A concept opposite to therapeutic inertia.","volume":"67","author":"Rodrigo","year":"2013","journal-title":"Int J Clin Pract"},{"key":"R39-20250306","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.147.3MA6.567","article-title":"How generalizable is freestanding children\u2019s hospital data such as PHIS (Pediatric Health Information System)?","volume":"147","author":"Harrington","year":"2021","journal-title":"Pediatrics"},{"key":"R40-20250306","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s13104-015-1550-9","article-title":"Cross-sectional comparison of critically ill pediatric patients across hospitals with various levels of pediatric care.","volume":"8","author":"Benneyworth","year":"2015","journal-title":"BMC Res Notes"},{"key":"R41-20250306","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/hpeds.2023-007397","article-title":"Probabilistic linkage creates a novel database to study bronchiolitis care in the PICU.","volume":"14","author":"Flaherty","year":"2024","journal-title":"Hosp Pediatr"},{"key":"R42-20250306","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PCC.0000000000003335","article-title":"Implementation science research in pediatric critical care medicine.","volume":"24","author":"Woods-Hill","year":"2023","journal-title":"Pediatr Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:03:43Z","timestamp":1741273423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003670","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}